Showing results (61-70 of 142) with videos related to
Sort By:
Pageof 15
The Journal of Antimicrobial Chemotherapy|January 1, 2017
Inhibition of β-lactamases of mycobacteria by avibactam and clavulanateDaria Soroka, Clément Ourghanlian, Fabrice Compain, et al.The Journal of Antimicrobial Chemotherapy|October 18, 2013
Characterization of broad-spectrum Mycobacterium abscessus class A β-lactamaseDaria Soroka, Vincent Dubée, Olivia Soulier-Escrihuela, et al.Journal of Clinical Microbiology|August 10, 2007
Dolosigranulum pigrum causing nosocomial pneumonia and septicemiaHervé Lécuyer, Juliette Audibert, Astrid Bobigny, et al.Journal of Bacteriology|April 15, 2008
The peptidoglycan of stationary-phase Mycobacterium tuberculosis predominantly contains cross-links generated by L,D-transpeptidationMarie Lavollay, Michel Arthur, Martine Fourgeaud, et al.Antimicrobial Agents and Chemotherapy|March 4, 2015
Impact of β-lactamase inhibition on the activity of ceftaroline against Mycobacterium tuberculosis and Mycobacterium abscessusVincent Dubée, Daria Soroka, Mélanie Cortes, et al.European Heart Journal. Acute Cardiovascular Care|January 29, 2020
Predictive factors of death associated with infective endocarditis in adult patients with congenital heart diseaseReaksmei Ly, Fabrice Compain, Bamba Gaye, et al.Journal of Clinical Microbiology|September 7, 2006
Hip prosthesis infection due to Mycobacterium wolinskyiCéline Pulcini, Eric Vandenbussche, Isabelle Podglajen, et al.Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 16, 2017
Clinical outcome of cystic fibrosis patients colonized by Scedosporium species following lung transplantation: A single-center 15-year experiencePerrine Parize, Veronique Boussaud, Vianney Poinsignon, et al.The Pediatric Infectious Disease Journal|February 19, 2025
Evaluation of Ceftazidime-avibactam and Ceftolozane-tazobactam Prescriptions in a Tertiary Hospital for Children in France: An Observational Study, 2017-2022Pauline Labé, Maya Husain, Perrine Parize, et al.The Journal of Antimicrobial Chemotherapy|June 1, 2023
Advances in antibacterial treatment of adults with high-risk febrile neutropeniaAdrien Contejean, Alexis Maillard, Etienne Canouï, et al.Pageof 15